NEW YORK (GenomeWeb News) – Response Genetics said this week that it is expanding its sales force for its ResponseDx genetic test panels by 50 percent.

Los Angeles-based Response Genetics said that it would increase its internal sales force from 10 to 15 to sell ResponseDx, a PCR-based test used to analyze the expression of genes that correlate to commonly used chemotherapy agents.

The company said that it plans to add the sales representatives to its sales force by the end of the first quarter this year.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

The New York City medical examiner is overseeing an effort to identify missing persons using DNA, according to the Associated Press.

Nobel laureate Günter Blobel has died at 81, the New York Times reports.

In PNAS this week: mouse model of genetically induced emphysema, gene expression signatures of circulating melanoma cells, and more.

Technology Review reports that 2017 was the year of consumer genetic testing and that it could spur new analysis companies.